Article
Preoperative Metabolic-Inflammatory Burden Index for
Individualized Selection Between Anterior and
Retzius-Sparing Robot-Assisted Radical Prostatectomy:
A Retrospective Cohort Study
Ruonan Qu, Zelin Li, Shangxuan Liu, Fangqiu Yu, Yixuan Li, Wenqiang An, Yan Chen, Zhiqiang Wen, Wei Wang, Zhongjin Yue
Online available: 2026-10-24
Download PDF (6)
Knowledge map
Save
Background: Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) has been associated with improved early postoperative
urinary continence (UC) recovery in patients with prostate cancer (PCa); however, its oncologic safety remains controversial.
Preoperative metabolic abnormalities and systemic inflammation may also influence functional and oncologic outcomes.
This study aimed to develop a preoperative Metabolic-Inflammatory Burden Index (MIBI) and evaluate its association with functional
and oncologic outcomes in patients undergoing anterior robot-assisted radical prostatectomy (RARP) or RS-RARP.
Methods: This single-center retrospective cohort study included 344 patients with PCa who underwent RARP at Lanzhou University
Second Hospital between January 2021 and December 2024. The primary endpoints were immediate postoperative UC,
continence recovery, positive surgical margin (PSM), and biochemical recurrence (BCR). Subgroup analyses, logistic regression,
and Kaplan–Meier survival analyses were performed to evaluate the associations of surgical approach, MIBI, and clinicopathological
factors with postoperative outcomes.
Results: Compared with anterior RARP, RS-RARP was associated with a higher immediate postoperative continence rate (67.4%
vs. 46.4%; relative risk (RR) = 1.45, 95% confidence interval (CI): 1.20–1.76, p < 0.001), and this association was consistent in
both the low-MIBI and high-MIBI subgroups. Multivariable logistic regression showed that pT3a stage (odds ratio (OR) = 2.03,
95% CI: 1.08–3.81, p = 0.028), pT3b stage (OR = 4.84, 95% CI: 2.47–9.48, p < 0.001), and higher MIBI levels were independently
associated with PSM; patients in MIBI Q3 and Q4 had a significantly higher risk of PSM. Subgroup analysis identified a
significant interaction between MIBI and surgical approach in relation to PSM risk (p for interaction = 0.004): RS-RARP was
associated with a higher risk of PSM in patients with low MIBI but with a lower risk in those with high MIBI. Survival analysis
showed that patients with high MIBI had a significantly higher risk of BCR and slower continence recovery. In contrast, RS-RARP
was associated with faster continence recovery.
Conclusions: Higher MIBI and advanced pathological T stage were independently associated with PSM, while high MIBI was
also associated with an increased risk of BCR and delayed continence recovery. MIBI may significantly modify the relationship
between surgical approach and PSM risk.